The BLDC gave Ginkgo Bioworks their first financing as a startup—a $150,000 loan, or as Gingko co-founder Barry Canton stated in a CNBC article,

When Ginkgo was a brand-new, five-person company, the city helped us find a home and provided loan programs to help us get off the ground.

Today the organism company, which designs custom microbes for customers across multiple markets, is worth over $1 billion. The company’s organism engineers work directly with customers including Fortune 500 companies and government entities to design microbes for their needs—applications including nutrition, health and consumer goods. Gingko is still a BPDA tenant in the Flynn Industrial Park and has created hundreds of jobs.

The following article details Gingko’s $25 million commitment to creating diagnostic vaccination and therapeutic solutions to the COVID-19 crisis.

Read more at gingkobioworks.com